FDA 483 - New York Presbyterian Hospital Services - September 10, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of NewYork-Presbyterian/Weill Cornell Medical Center in New York identified significant deficiencies in their blood bank operations. The facility failed to consistently follow written standard operating procedures for the distribution of blood and blood components, including issues with visual inspections and accurate record-keeping for mass hemorrhage protocols. Additionally, the firm did not maintain adequate processing, quality control, and general records, with specific concerns regarding documentation for reconstituted whole blood, temperature monitoring, reagent preparation, and investigation of testing discrepancies.
- Inspection Date
- September 10, 2025
- Product Type
- Biologics
ID · 199688c2-353b-47b0-859e-cd9254cf4289